AP: Sanofi, GSK to provide COVID-19 vaccine to global alliance “Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around the world equal access to coronavirus vaccines…” (10/28). Bloomberg: Sanofi, Glaxo to Supply…

Financial Times: Pfizer urges patience in ‘last mile’ of Covid-19 vaccine process “Pfizer’s chief executive has urged patience in the ‘last mile’ of Covid-19 vaccine development, after the timeline for an early look at whether a late-stage trial shows its vaccine works was poised to slip into November. Albert Bourla said…

The Hill: NIH halts study of Eli Lilly antibody drug for treating hospitalized COVID-19 patients “Federal researchers have ended a study into the effectiveness of Eli Lilly’s antibody treatment for hospitalized COVID-19 patients due to a lack of effectiveness. The National Institute of Allergy and Infectious Diseases (NIAID), which is…

Bloomberg: Covid-Vaccine Developer in India Plans to Boost Capacity by 70% (Kay, 10/26). CNBC: AstraZeneca says its coronavirus vaccine triggers immune response among adults (Meredith, 10/26). CNN: CNN interviews chief of institute developing Russia’s Sputnik V vaccine (Pleitgen, 10/26). Financial Times: Mexico uses human trials as path to secure future…

AP: Vaccine storage issues could leave 3B people without access (Hinnant/Mednick, 10/25). AP: Brazil approves import of Chinese shot that Bolsonaro nixed (Sciaudone, 10/23). Bloomberg: Venezuela’s Maduro Presents ‘Molecule’ That Inhibits Covid-19 (Zerpa, 10/25). Bloomberg: Johnson & Johnson, AstraZeneca Trials to Resume, Rejoining Vaccine Race (Griffin et al., 10/24). DW:…

Christian Science Monitor: The unexpected key to fighting a pandemic: Compassion Ned Temko, correspondent for Christian Science Monitor (10/22). The Conversation: Children may need to be vaccinated against COVID-19 too. Here’s what we need to consider Ketaki Sharma, PhD student at the University of Sydney, and colleagues (10/22). Devex: Opinion:…

Reuters: AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue “Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue. … A source familiar with the…

Devex: How to encourage and nurture an innovation mindset in eye health Anurag Hans, leads the Base of Pyramid innovation, strategy, and operation team at Essilor International “For those of us working in the development sector, the last months have undoubtedly been challenging, with resources rightly diverted to dealing with…

Devex: What do people in BRICS countries think about a COVID-19 vaccine? “Vaccine hesitancy will prove a steep challenge for global efforts to find a safe and effective coronavirus vaccine and ensure its equitable distribution, new evidence suggests. About 28% of 13,400 individuals from 19 countries would hesitate to get,…

NBC News: Massive WHO remdesivir study suggests no Covid-19 benefit. Doctors aren’t so sure. “A huge, global study of potential medications to treat Covid-19 suggests remdesivir — one of the few available drugs for the virus — may offer no real benefit to the sickest patients. But doctors on the…